miR-608 rs4919510 C>G polymorphism decreased the risk of breast cancer in an Iranian subpopulation
dc.contributor.author | Hashemi, M. | |
dc.contributor.author | Sanaei, S. | |
dc.contributor.author | Rezaei, M. | |
dc.contributor.author | Bahari, G. | |
dc.contributor.author | Hashemi, S.M. | |
dc.contributor.author | Mashhadi, M.A. | |
dc.contributor.author | Taheri, M. | |
dc.contributor.author | Ghavami, S. | |
dc.date.accessioned | 2018-06-22T14:24:59Z | |
dc.date.available | 2018-06-22T14:24:59Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Aim: MicroRNAs (miRNAs) are small noncoding RNAs that function as oncogene or tumor suppressors. The single nucleotide polymorphisms in miRNAs potentially can alter miRNA-binding sites on target genes as well as affecting miRNAs expression. The present study aimed to evaluate the impact of miR-608 rs4919510 C>G variant on breast cancer (BC) risk. Materials and Methods: This case-control study conducted on 160 women with BC and 192 age-matched healthy women. Genotyping of miR608 rs4919510 was done using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results: Our findings showed that GC genotype significantly decreased the risk of BC (odds ratio (OR) = 0.49, 95% confidence interval (CI) 0.28–0.88, p = 0.018) compared to CC genotype. Furthermore the G allele decreased the risk of BC (OR = 0.53, 95%CI 0.30–0.92, p = 0.024). No significant association was found between miR-609 genotypes and clinicopathological characteristics of BC patients (p > 0.05). Conclusion: Our findings indicate that miR-608 polymorphism might be associated with decreased risk of BC in an Iranian subpopulation. Further large-scale studies with different ethnicities are needed to verify our findings. | uk_UA |
dc.description.sponsorship | This paper was funded by a research grant from the Deputy for Research, Zahedan University of Medical Sciences. | uk_UA |
dc.identifier.citation | miR-608 rs4919510 C>G polymorphism decreased the risk of breast cancer in an Iranian subpopulation / M. Hashemi, S. Sanaei, M. Rezaei, G. Bahari, S.M. Hashemi, M.A. Mashhadi, M. Taheri,S. Ghavami // Experimental Oncology. — 2016 — Т. 38, № 1. — С. 57-59. — Бібліогр.: 31 назв. — англ. | uk_UA |
dc.identifier.issn | 1812-9269 | |
dc.identifier.uri | https://nasplib.isofts.kiev.ua/handle/123456789/140089 | |
dc.language.iso | en | uk_UA |
dc.publisher | Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України | uk_UA |
dc.relation.ispartof | Experimental Oncology | |
dc.status | published earlier | uk_UA |
dc.subject | Short communications | uk_UA |
dc.title | miR-608 rs4919510 C>G polymorphism decreased the risk of breast cancer in an Iranian subpopulation | uk_UA |
dc.type | Article | uk_UA |
Файли
Оригінальний контейнер
1 - 1 з 1
Завантаження...
- Назва:
- 12-Hashemi.pdf
- Розмір:
- 280.87 KB
- Формат:
- Adobe Portable Document Format
- Опис:
- Стаття
Контейнер ліцензії
1 - 1 з 1
Завантаження...
- Назва:
- license.txt
- Розмір:
- 817 B
- Формат:
- Item-specific license agreed upon to submission
- Опис: